ArticleVirchows Archiv : an international journal of pathology2026

HER2 intratumoral heterogeneity predicts response to neoadjuvant therapy in HER2-positive breast cancer: impact and interplay with HER3 expression.

Angela Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.